These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 27430985

  • 1. An assessment tumor targeting ability of (177)Lu labeled cyclic CCK analogue peptide by binding with cholecystokinin receptor.
    Cho EH, Lim JC, Lee SY, Jung SH.
    J Pharmacol Sci; 2016 Jul; 131(3):209-14. PubMed ID: 27430985
    [Abstract] [Full Text] [Related]

  • 2. Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation.
    Roosenburg S, Laverman P, Joosten L, Eek A, Oyen WJ, de Jong M, Rutjes FP, van Delft FL, Boerman OC.
    Bioconjug Chem; 2010 Apr 21; 21(4):663-70. PubMed ID: 20302291
    [Abstract] [Full Text] [Related]

  • 3. Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer.
    Günther T, Holzleitner N, Viering O, Beck R, Wienand G, Dierks A, Pfob CH, Bundschuh RA, Kircher M, Lapa C, Wester HJ.
    J Nucl Med; 2024 Jan 02; 65(1):33-39. PubMed ID: 37945383
    [Abstract] [Full Text] [Related]

  • 4. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
    de Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP.
    J Nucl Med; 1999 Dec 02; 40(12):2081-7. PubMed ID: 10616889
    [Abstract] [Full Text] [Related]

  • 5.
    Chopra A.
    ; 2004 Dec 02. PubMed ID: 22855967
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M, Lignon MF, Galas MC, Fulcrand P, Mendre C, Aumelas A, Laur J, Martinez J.
    J Med Chem; 1987 Aug 02; 30(8):1366-73. PubMed ID: 2441054
    [Abstract] [Full Text] [Related]

  • 7.
    Chopra A.
    ; 2004 Aug 02. PubMed ID: 23390667
    [Abstract] [Full Text] [Related]

  • 8.
    Chopra A.
    ; 2004 Aug 02. PubMed ID: 22787691
    [Abstract] [Full Text] [Related]

  • 9.
    Chopra A.
    ; 2004 Aug 02. PubMed ID: 23390663
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
    Charpentier B, Dor A, Roy P, England P, Pham H, Durieux C, Roques BP.
    J Med Chem; 1989 Jun 02; 32(6):1184-90. PubMed ID: 2724293
    [Abstract] [Full Text] [Related]

  • 11. Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?
    Sauter AW, Mansi R, Hassiepen U, Muller L, Panigada T, Wiehr S, Wild AM, Geistlich S, Béhé M, Rottenburger C, Wild D, Fani M.
    J Nucl Med; 2019 Mar 02; 60(3):393-399. PubMed ID: 30002107
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of Ibuprofen as an Albumin Binder on Melanoma-Targeting Properties of 177Lu-Labeled Ibuprofen-Conjugated Alpha-Melanocyte-Stimulating Hormone Peptides.
    Qiao Z, Xu J, Gallazzi F, Fisher DR, Gonzalez R, Kwak J, Miao Y.
    Mol Pharm; 2024 Aug 05; 21(8):4004-4011. PubMed ID: 38973113
    [Abstract] [Full Text] [Related]

  • 15.
    Cheng KT.
    ; 2004 Aug 05. PubMed ID: 20641374
    [Abstract] [Full Text] [Related]

  • 16. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM, Jenner N, Béhé M, Angerstein C, Gratz S, Raue F, Becker W.
    J Nucl Med; 1999 Jun 05; 40(6):1029-44. PubMed ID: 10452322
    [Abstract] [Full Text] [Related]

  • 17. Biological evaluation of (177)Lu-labeled DOTA-Ala(SO3H)-Aminooctanoyl-Gln-Trp-Ala-Val-N methyl Gly-His-Statine-Leu-NH2 for gastrin-releasing peptide receptor-positive prostate tumor targeting.
    Lim JC, Cho EH, Kim JJ, Choi SM, Lee Sy, Nam SS, Park UJ, Park SH.
    Nucl Med Biol; 2015 Feb 05; 42(2):131-6. PubMed ID: 25457455
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.